HOOKIPA Pharma Inc.
NASDAQ:HOOK
Overview | Financials
Company Name | HOOKIPA Pharma Inc. |
Symbol | HOOK |
Currency | USD |
Price | 3.76 |
Market Cap | 45,325,067 |
Dividend Yield | 0% |
52-week-range | 3.415 - 11.3 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Joern Aldag |
Website | https://www.hookipapharma.com |
An error occurred while fetching data.
About HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD